glp 1 coverage How many adults with private health insurance could use GLP-1 drugs How Employers Can Manage GLP-1

Currently, 70% of the GLP-1 market is in the US and partially the EU, with a staggering 300% growth from 2020 to 2023 in prescriptions within the US alone

At 10mg/ml, you are drawing 75 units, which is manageable but getting close to the upper end

Patients taking semaglutide showed considerable improvement compared to those on placebo, potentially positioning semaglutide as a promising option for MASH

The fast-changing landscape, which includes the expected entry of new drugs and generic competition, has led to a recalculation of what the peak will be and when those heights may be reached, analysts and investors say